Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
about
Evolution of cooperation among tumor cellsCancer Stem Cell Plasticity Drives Therapeutic ResistanceLeptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemmaAssociation of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinomaHiJAK'd Signaling; the STAT3 Paradox in Senescence and Cancer Progression.Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study.c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M.Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.The antitumor potential of Interleukin-27 in prostate cancer.Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in ratsHigh LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.Promoter methylation of leukemia inhibitory factor receptor gene in colorectal carcinomaFirst steps in experimental cancer evolution.Accumulation of Palmitoylcarnitine and Its Effect on Pro-Inflammatory Pathways and Calcium Influx in Prostate Cancer.Interleukin-6 and oncostatin-M synergize with the PI3K/AKT pathway to promote aggressive prostate malignancy in mouse and human tissuesaPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract SymptomsThe enigmatic cytokine oncostatin m and roles in diseaseIL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Cell mates: paracrine and stromal targets for prostate cancer therapy.gp130: a promising drug target for cancer therapy.STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL.A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation.Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro.Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer.Androgen-independent effects of Serenoa repens extract (Prostasan®) on prostatic epithelial cell proliferation and inflammation.Malignancy through cooperation: an evolutionary game theory approach.S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.Expression of interleukin-6 is downregulated by 17-(allylamino)-17-demethoxygeldanamycin in human prostatic carcinoma cells.Stereological evaluation of fibronectin in the periurethral region of the transitional zone from normal human prostates compared with benign prostatic hyperplasia.Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.CD4+ and CD8+ T-lymphocyte scores cannot reliably predict progression in patients with benign prostatic hyperplasia.Coexpression of aPKCλ/ι and IL-6 in prostate cancer tissue correlates with biochemical recurrence.
P2860
Q24671009-C076279F-6EC6-45C7-957F-409C0288A946Q26770274-BB4ABC0F-4B65-435D-A7CB-3766972D164EQ26786149-7EE252BC-6D18-447D-B0A5-5FC67ED4A50FQ28543497-162B2232-7613-46A5-A1A8-ADFD685B32EFQ33820241-10F4F4FD-FA27-4280-A42A-4EE0228627A5Q33968366-52F36025-0EDC-41E9-8D9F-B8ED43AC944DQ33975103-CF03A5D1-9FA8-422D-8BDF-962A95A0B846Q34658788-698CEB82-9801-455E-836B-652CFCFD4B41Q34786440-E7040998-BEB1-4C1D-8C37-FCC7F6D760D8Q35468651-307248AE-8B11-4FB4-A6AA-C11027D1234AQ36413212-ACB4A06B-8596-45E1-939A-A95035790658Q36694634-01E37056-2CF8-44CE-B05B-0795E699FE63Q36904971-417DE831-E578-4E6B-8430-B8B36A31852BQ37200709-28887281-24E4-4561-AE8F-3CF8D808D639Q37239331-AAEAABBD-A91E-4817-9D30-A6121E2250E3Q37364129-7B847000-C6AC-44AD-A40E-3ED7184CBD1EQ37376015-878DB0A3-A420-490E-8D6B-A65A14BCEE6FQ37409222-8DBF0F2E-F2C4-43ED-94D0-4755E727F7CEQ37968599-0E482137-18AA-4725-A816-EECE5F31A0FBQ38121792-E92A4269-4734-4F10-98FC-4FD41360E579Q38149939-8A48A447-D2A4-4546-BD67-138B4F84662AQ38790057-2BA16A6F-3919-4A9F-A24A-70A25CE8CE1EQ38845188-8DC02A9F-CCD5-4FFA-B721-A3875DC7B876Q38866860-F4A75929-7962-4064-B6AA-962F582B4C67Q39020147-08A1141F-86C2-4851-8A67-C7589C617CCCQ39069108-2CC8A459-034C-49C8-B409-724AEE10B533Q39139830-054DB2E3-9570-4296-8370-9AC592BF6029Q39527993-F80C12C8-9594-497E-AEA8-40477CFADB24Q39616030-D7F89C67-6C4B-443D-A439-594288FEAECCQ39747948-5A70F230-A152-42EC-9815-D8A45075CC9BQ39924684-7DFD425A-CF6C-4243-B488-F904E79F6248Q40813190-44FDCEB6-D689-4164-A20E-CC6721D8A915Q47887279-15F56091-3881-4292-9F72-532A25A1792EQ53155963-5734E466-57F9-4956-B737-337A862BBFB6Q54593106-1C74150D-360F-4D35-961D-D825D2290541
P2860
Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immunohistochemical analysis o ...... and malignant human prostate.
@en
Immunohistochemical analysis o ...... and malignant human prostate.
@nl
type
label
Immunohistochemical analysis o ...... and malignant human prostate.
@en
Immunohistochemical analysis o ...... and malignant human prostate.
@nl
prefLabel
Immunohistochemical analysis o ...... and malignant human prostate.
@en
Immunohistochemical analysis o ...... and malignant human prostate.
@nl
P2093
P356
P1476
Immunohistochemical analysis o ...... , and malignant human prostate
@en
P2093
Mar Royuela
Maria P de Miguel
Melanie S Parsons
Monica Ricote
Ricardo Paniagua
P356
10.1002/PATH.1476
P577
2004-01-01T00:00:00Z